Evidence map›Paper›PMID 40158013›Full record

ArticleScientific reports2025

Genetic targeting of myelinated primary afferent neurons using a new Nefh

John Cy Chen, Lech Kaczmarczyk, Felipe Meira de-Faria, Marcin Szczot, Walker S Jackson, Max Larsson

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

John Cy ChenDivision of Cell- and Neurobiology, Department of Biomedical and Clinical Sciences, Linköping University, 581 85, Linköping, Sweden.
Lech KaczmarczykDivision of Cell- and Neurobiology, Department of Biomedical and Clinical Sciences, Linköping University, 581 85, Linköping, Sweden.
Felipe Meira de-FariaDepartment of Biomedical and Clinical Sciences, Center for Social and Affective Neuroscience, Linköping University, 581 85, Linköping, Sweden.
Marcin SzczotDepartment of Biomedical and Clinical Sciences, Center for Social and Affective Neuroscience, Linköping University, 581 85, Linköping, Sweden.
Walker S JacksonDivision of Cell- and Neurobiology, Department of Biomedical and Clinical Sciences, Linköping University, 581 85, Linköping, Sweden.
Max LarssonDivision of Cell- and Neurobiology, Department of Biomedical and Clinical Sciences, Linköping University, 581 85, Linköping, Sweden. max.larsson@liu.se.

Funding

Knut och Alice Wallenbergs Stiftelse 2019.0047
6 · The paper itself

Abstract

Primary afferent neurons that convey somatosensory modalities comprise two large, heterogeneous populations: small-diameter neurons that give rise to slowly conducting unmyelinated axonal C fibers and medium-to-large diameter neurons with fast myelinated A fibers. Despite these two major groupings, tools to differentiate between unmyelinated and myelinated primary afferent fibers by genetic targeting have not been available; in particular, whereas numerous mouse driver lines exist to target different C fiber populations, genetic tools that target myelinated primary afferent populations are scarce. Here we describe a knock-in mouse line expressing tamoxifen-dependent CreERT2 under control of the Nefh gene, which encodes neurofilament heavy chain (NFH or NF200), a protein that is highly enriched in myelinated fibers. This mouse enables highly selective and efficient recombination of Cre-dependent reporters for functional and anatomical interrogation of myelinated fibers while excluding unmyelinated C fibers. In combination with other recombinase-expressing mouse lines, this genetic tool will be valuable for intersectional targeting of subpopulations of myelinated primary afferent fibers.

Indexed as

Gene Knock-In TechniquesGene TargetingIntegrasesNerve Fibers, MyelinatedNeurofilament ProteinsNeurons, AfferentAnimalsMiceMice, TransgenicTamoxifenCre recombinaseIntegrasesneurofilament protein HNeurofilament ProteinsTamoxifen

Identifiers

PMID40158013
PMCPMC11954935

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.